{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T16:32:54Z","timestamp":1774456374182,"version":"3.50.1"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2,3]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Primary intracranial malignant melanoma (PIMM) is a rare malignant tumor that lacks specific clinical manifestations. Preoperative diagnosis is difficult to differentiate from meningiomas on computed tomography (CT) scans. Magnetic resonance imaging (MRI) usually shows typical characteristics with high signal intensity on T1WI and low signal intensity on T2WI. PIMM is highly invasive, insensitive to chemoradiotherapy, and has a poor prognosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 27-year-old woman was admitted to the hospital with a headache for 10 days. She did not experience nausea, vomiting, dizziness, or any other discomfort. A computerized tomography (CT) scan demonstrated a high-density mass in the left cerebellum with patchy calcification at the posterior edge, and heterogeneous enhancement was observed on a contrast-enhanced scan. MRI revealed typical characteristics of high signal intensity on T1WI and low signal intensity on T2WI. The signal characteristics of FLAIR were similar to those of T2WI, and diffusion-weighted imaging (DWI) sequence showed limited diffusion of the tumor. Magnetic resonance spectroscopy revealed increased choline (Cho) and decreased creatine (Cr) and N-acetyl aspartate (Naa) in the tumor.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient underwent tumor resection and postoperative chemoradiotherapy and immunotherapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Pathological diagnosis:<\/jats:title>\n            <jats:p>Histological and Immunohistochemistry (IHC) tests confirmed the diagnosis of PIMM. In addition, genetic testing revealed GNAQ gene variation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>No recurrence or complications were observed during the follow-up for 6 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>PIMM is rare, and its pathological diagnosis should be closely combined with clinical and medical history. GNAQ is a common variant of PIMM and is expected to be a therapeutic target.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000032767","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T15:11:44Z","timestamp":1675782704000},"page":"e32767","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Imaging and pathological diagnosis of primary intracranial malignant melanoma: A case report and literature review"],"prefix":"10.1097","volume":"102","author":[{"given":"Wei-Li","family":"Long","sequence":"first","affiliation":[{"name":"Department of Pathology, Luzhou People\u2019s Hospital, Luzhou, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Yong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiology, Luzhou People\u2019s Hospital, Luzhou, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Lin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Luzhou People\u2019s Hospital, Luzhou, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Xu","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Luzhou People\u2019s Hospital, Luzhou, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Neng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/bpa.12241","article-title":"Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspects.","volume":"25","author":"K\u00fcsters-Vandevelde","year":"2015","journal-title":"Brain Pathol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary.","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"e782","DOI":"10.1016\/j.wneu.2019.06.030","article-title":"Incidence, outcomes and predictors of primary central nervous system melanoma: a SEER-based study.","volume":"129","author":"Man","year":"2019","journal-title":"World Neurosurg"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"e926749","DOI":"10.12659\/AJCR.926749","article-title":"Primary brain melanoma in a pediatric patient: a case report.","volume":"22","author":"Otero-Soto","year":"2021","journal-title":"Am J Case Rep"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"e5805","DOI":"10.1097\/MD.0000000000005805","article-title":"Primary cerebral malignant melanoma: a case report with literature review.","volume":"96","author":"Tang","year":"2017","journal-title":"Medicine (Baltim)"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.wneu.2018.06.138","article-title":"Primary solitary intracranial malignant melanoma: a systematic review of literature.","volume":"117","author":"Arai","year":"2018","journal-title":"World Neurosurg"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.4103\/0028-3886.217953","article-title":"Advanced magnetic resonance imaging in the diagnosis of primary intracranial malignant melanoma.","volume":"65","author":"Saranya","year":"2017","journal-title":"Neurol India"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.3892\/ol.2015.3537","article-title":"Intracranial malignant melanoma: a report of 7 cases.","volume":"10","author":"Ma","year":"2015","journal-title":"Oncol Lett"},{"key":"R9-20250504","first-page":"293802","article-title":"Primary intracranial melanoma with early leptomeningeal spread: a case report and treatment options available.","volume":"2015","author":"Balakrishnan","year":"2015","journal-title":"Case Rep Oncol Med"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11060-015-2052-2","article-title":"Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.","volume":"127","author":"van de Nes","year":"2016","journal-title":"J Neurooncol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00401-009-0611-3","article-title":"Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system.","volume":"119","author":"K\u00fcsters-Vandevelde","year":"2010","journal-title":"Acta Neuropathol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40618-019-01158-8","article-title":"Primary sellar melanocytoma: pathological, clinical and treatment review.","volume":"43","author":"Albano","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4103\/1793-5482.224832","article-title":"A unique case of primary intracranial melanoma.","volume":"13","author":"Sarmast","year":"2018","journal-title":"Asian J Neurosurg"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/0145561319826542","article-title":"Pigmented melanotic schwannoma of the neck: report of 2 cases and review of the literature.","volume":"98","author":"Topf","year":"2019","journal-title":"Ear Nose Throat J"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clineuro.2017.11.012","article-title":"Clinical outcomes of primary intracranial malignant melanoma and metastatic intracranial malignant melanoma.","volume":"164","author":"Byun","year":"2018","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032767","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:45:10Z","timestamp":1746326710000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032767","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,3]]}}}